Smallpox vaccine (NYCBH vaccinia strain, Sanofi Pasteur/NIAID)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSmallpox vaccine (NYCBH vaccinia strain, Sanofi Pasteur/NIAID)
Drug Alias NameVaccinia virus vaccine - NIAID/Aventis PasteurNYCBH vaccinia strain smallpox vaccine - Aventis PasteurAventis Pasteur smallpox vaccine (APSV)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSmallpoxHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Sanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi PasteurNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsSmallpoxHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A